alexa Omega-3 Polyunsaturated Fatty Acids In Cardiovascular Disease And Cancer: A Prospective Alternative
ISSN: 2155-9880

Journal of Clinical & Experimental Cardiology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

Joint Conference on 17th European Heart Disease and Heart Failure Congress and 2nd International Conference on Cardiovascular Medicine and Cardiac Surgery
March 15-17, 2017 London, UK

Renata Ottes Vasconcelos
Cancer Institute of São Paulo, Brazil
Posters & Accepted Abstracts: J Clin Exp Cardiolog
DOI: 10.4172/2155-9880.C1.066
Recently, in vitro and in vivo research has demonstrated the beneficial role of omega-3 polyunsaturated fatty acids (omega-3 PUFA) as potential adjuvants for prevention and treatment of many disorders, including cardiovascular disease and cancer. Plenty of works have demonstrated the ability of omega-3 PUFA to exert antitumor activity in different kinds of cancer cells through several mechanisms, including the inhibitory effect on inflammation and cancer cell proliferation, as well as apoptosis induction. Moreover, epidemiological research and clinical interventions have demonstrated that achievable daily doses of omega-3 PUFA are able to decrease the risk of unstable angina, myocardial infarction, and sudden cardiac death, as well as death related to coronary artery disease and heart failure. It is extremely important to establish a relationship between cancer and cardiovascular diseases related to cancer treatments, since, nowadays, it is well-known that several anticancer drugs are cardio toxic, and can cause heart failure. The discussion will focus on the need of a better comprehension of the effects of omega-3 PUFA on the cardiovascular system of cancer patients. Moreover, the most recent results on the beneficial effects of omega-3 PUFA will be reviewed, by particularly focusing on cancer and cardiovascular diseases related to cancer treatments. Results obtained recently by us, and demonstrating the protective role exerted by these fatty acids in normal and malignant melanocytes, will be illustrated. Our results supporting the potential role of omega-3 PUFA as powerful adjuvants in combination with cisplatin will be shown. The need for new and well conducted preclinical studies and clinical interventional trials designed to better explore this research field and answer to many unresolved questions will be discussed.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version